Page last updated: 2024-08-22

zirconium and Angiogenesis, Pathologic

zirconium has been researched along with Angiogenesis, Pathologic in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hatano, K; Iizumi, Y; Ishikawa, E; Joraku, A; Masuda, Y; Matsuda, M; Matsumura, A; Nishiyama, H; Yamamoto, T1
Arjaans, M; de Vries, EG; Garbacik, ET; Gietema, JA; Lub-de Hooge, MN; Oosting, SF; Oude Munnink, TH; Schröder, CP; Terwisscha van Scheltinga, AG; Timmer-Bosscha, H1
de Jong, JR; de Korte, MA; de Vries, EG; den Dunnen, WF; Garcia-Echeverria, C; Hollema, H; Jensen, MR; Lub-de Hooge, MN; Nagengast, WB; Oude Munnink, TH; Quadt, C; Schröder, CP; Timmer-Bosscha, H; van Dongen, GA1
Holland, JP; Lewis, JS; May, C; McDevitt, MR; Ruggiero, A; Scheinberg, DA; Sprinkle, SR; Villa, CH1

Other Studies

4 other study(ies) available for zirconium and Angiogenesis, Pathologic

ArticleYear
Potential use of prostate specific membrane antigen (PSMA) for detecting the tumor neovasculature of brain tumors by PET imaging with
    Journal of neuro-oncology, 2018, Volume: 138, Issue:3

    Topics: Adult; Aged; Antigens, Surface; Brain; Brain Neoplasms; Endothelium, Vascular; Female; Glioma; Glutamate Carboxypeptidase II; Humans; Immunoglobulins; Lung Neoplasms; Lymphoma; Male; Middle Aged; Necrosis; Neovascularization, Pathologic; Positron-Emission Tomography; Radiation Injuries; Radioisotopes; Radiopharmaceuticals; Zirconium

2018
Bevacizumab-induced normalization of blood vessels in tumors hampers antibody uptake.
    Cancer research, 2013, Jun-01, Volume: 73, Issue:11

    Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Cell Line, Tumor; Drug Interactions; Esophageal Neoplasms; Female; Humans; Immunoglobulin G; Male; Mice; Mice, Nude; Neovascularization, Pathologic; Ovarian Neoplasms; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Trastuzumab; Xenograft Model Antitumor Assays; Zirconium

2013
89Zr-bevacizumab PET of early antiangiogenic tumor response to treatment with HSP90 inhibitor NVP-AUY922.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2010, Volume: 51, Issue:5

    Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Cisplatin; Drug Resistance, Neoplasm; Female; HSP90 Heat-Shock Proteins; Immunohistochemistry; Isoxazoles; Ki-67 Antigen; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms; Neovascularization, Pathologic; Ovarian Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Resorcinols; Tissue Distribution; Vascular Endothelial Growth Factor A; Zirconium

2010
Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes.
    International journal of nanomedicine, 2010, Oct-05, Volume: 5

    Topics: Actinium; Adenocarcinoma; Animals; Cell Line, Tumor; Colonic Neoplasms; Deferoxamine; Heterocyclic Compounds, 1-Ring; Humans; Male; Mice; Mice, Nude; Nanomedicine; Nanotubes, Carbon; Neovascularization, Pathologic; Positron-Emission Tomography; Radioimmunodetection; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Xenograft Model Antitumor Assays; Zirconium

2010